Clinical trial
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in…
NCT00005087 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005087 |
|---|---|
| Title | Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer |
| Official title | Phase II Study of Paclitaxel and Cisplatin in Combination With Split Course Concomitant Hyperfractionated Re-Irradiation in Patients With Recurrent Squamous Cell Cancer of the Head and Neck |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, cisplatin, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 105 |
| Start date | Mar 1, 2000 |
| Primary completion | Nov 1, 2004 |
| Completion | Nov 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 17, 2015 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: